Category: Op-Eds

Op-Ed: Republicans Siding With Big Banks in Stablecoin Fight Could Tank Trump’s Affordability Agenda

In his recent op-ed, “Republicans Siding With Big Banks in Stablecoin Fight Could Tank Trump’s Affordability Agenda,” John Czwartacki argues that emerging Republican support for restrictions favored by large banks in the stablecoin debate could undercut efforts to expand financial competition and lower costs for consumers.

Op-Ed: Why the Netflix–Warner Brothers Deal Should Be Approved

In his op-ed, Public Policy Solutions President Joe Grogan argues that Netflix’s proposed acquisition of Warner Bros. is not only pro-consumer but also pro-growth, innovation, and American creative leadership. He criticizes the current antitrust scrutiny, particularly under the Biden-era FTC, as overly hostile to business and driven by ideological biases rather than sound economic principles.

Experts Urge Trump Administration to Take Tough Stance Against EU Regulations Targeting US

A new report casts light on several European Union regulations wielded to disproportionately harm U.S. companies and consumers and urges the Trump administration to take broad action against them.

Davos braces for Trump as even he admits: ‘I have no idea what’s going to happen’

The snow-capped Swiss Alps town of Davos, Switzerland, is typically the picturesque backdrop for world leaders and corporate titans to hobnob and pose for photos at the World Economic Forum.

Op-Ed: How America Can Defuse the Alzheimer’s Economic Bomb

Joe Grogan’s recent op-ed, “How America Can Defuse the Alzheimer’s Economic Bomb,” argues that rising rates of Alzheimer’s disease threaten to overwhelm the U.S. economy by pushing more patients into costly long-term care, reducing workforce participation, and accelerating the insolvency of Social Security and entitlement programs. He calls on U.S. policymakers to make Alzheimer’s a national priority by expanding Medicare coverage for early detection tests, removing regulatory barriers to treatment, and embedding cognitive-health strategies into routine care.

Op-Ed: To make America healthy again, fight Alzheimer’s

John Czwartacki’s recent op-ed “To make America Healthy Again, Fight Alzheimer’s” argues that efforts to “Make America Healthy Again” should focus on fighting Alzheimer’s disease. He emphasizes that early diagnosis, timely treatments, and expanded research are essential because the toll of Alzheimer’s on patients, families, and society continues to grow. He cautions that delays in diagnosis waste valuable time, when intervention could slow disease progression and help Americans stay healthier longer. 

US trade officials push back on EU’s tech regulations amid tariff negotiations

Experts with Public Policy Solutions have deemed the EU’s administration of its digital regulations as a form of protectionism, but Lutnick argued that the EU and United States would mutually benefit from the EU easing up on its digital regulations, which disproportionately impact American companies.

Op-Ed: John Czwartacki: How to connect America’s heartland and fix Biden’s mess

In his recent op-ed, “How to connect America’s heartland and fix Biden’s mess,” John Czwartacki argues that the Broadband Equality, Access and Deployment (BEAD) Program, intended to bridge the digital divide in rural America, has become a bureaucratic burden filled with politically motivated requirements, leaving much of the $42 billion unspent. 

Squabbling lawmakers made $20K each during longest government shutdown in history

“Maybe the Democrats would have been more reluctant to shut the government down for a political stunt if they were forced to live like Americans who couldn’t get food stamps, or had their flights cancelled, or didn’t get paid for their work in a federal agency,” Grogan, who oversaw domestic healthcare spending of $1.3 trillion in the last Trump administration, told the Post.

OP-ED: Trump’s congressional allies finally move on 340B

Joe Grogan’s latest op-ed, “Trump’s congressional allies finally move on 340B,” highlights how congressional allies of President Trump are advancing long-awaited reforms to the federal 340B Drug Discount Program, which was designated to help hospitals serve low-income patients but has since ballooned into a system critics say benefits large health systems instead.